Eledon Pharmaceuticals, Inc. — Cash Flow Charts
5 years of history · ending 2017-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+3.5% +$535K
$-15M
Free Cash Flow↑+3.6% +$558K
$-15M
Investing Cash Flow↑+43983.0% +$23M
$23M
Financing Cash Flow↓-77.9% -$28M
$8M
Capex
$9K
Stock-Based Comp
$2M
D&A↑+120.0% +$12K
$22K
SBC Allocated Expense↑+143.3% +$341K
$579K
SBC Unrecognized Cost
$2M